Comparison of Tcm-tetrofosmin with Tl and I in the detection of differentiated thyroid cancer metastases

Nuclear Medicine Communications

Volumn 21, Issue 10, 2000, Pages 917-923

  Nishiyama, Y ^a   Yamamoto, Y ^b   Ono, Y ^b   Takahashi, K ^b   Nakano, S ^b   Satoh, K ^b   Ohkawa, M ^b   Tanabe, M ^b  

^a Department of Radiology ^*  (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE; THALLIUM;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE TUMOR; COMPARATIVE STUDY; DIAGNOSTIC ERROR; FEMALE; HUMAN; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; PAPILLARY CARCINOMA; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CARCINOMA, PAPILLARY; DIAGNOSTIC ERRORS; FEMALE; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; THALLIUM RADIOISOTOPES; THYROID NEOPLASMS;

EID: 0034292920     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200010000-00005     Document Type: Article

References (26)

1. Pacini F, Lippi F, Formica N et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987; 28: 1888-1891.
2. Sherman SI, Tielens SI, Sostre ET et al. Clinical utility of post treatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab 1994; 78: 629-634.
3. Dadparvar S, Krishana L, Brady LW et al. The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma. Cancer 1993; 71: 3767-3773.
4. Filesi M, Signore A, Ventroni G, Melacrinis FF, Ronga G. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases. J Nucl Med 1998; 39: 1542-1546.
5. Muratet JP, Daver A, Minier JF, Larra F. Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma. J Nucl Med 1998; 39: 1546-1550.
6. Franceschi M, Kusic Z, Franceschi D, Lukinac L, Roncevic S. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 1996; 37: 446-451.
7. Hoefnagel CA, Delfer CC, Marcuse HR et al. Role of thallium-201 total body scintigraphy in follow-up of thyroid carcinoma. J Nucl Med 1986; 27: 1854-1857.
8. Brendel AJ, Guyot M, Jeandot R, Lefort G, Manciet G. Thallium-201 imaging in the follow-up of differentiated thyroid carcinoma. J Nucl Med 1988; 29: 1515-1520.
9. Carril JM, Quirce R, Serrano J et al. Total body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer. J Nucl Med 1997; 38: 686-692.
10. Lorberdoym M, Murthy S, Mechanick JI, Bergman D, Morris JC, Kim CK. Thallium-201 and I-131 scintigraphy in differentiated thyroid carcinoma. J Nucl Med 1996; 37: 1487-1491.
11. Jones S, Hendel RC. Technetium-99m tetrofosmin: a new myocardial perfusion agent. J Nucl Med Technol 1993; 21: 191-195.
12. Lind P, Gallowitsch HJ, Langsteger W, Kresnik E, Mikosch P, Gomez I. Technetium-99m-tetrofosmin whole body scintigraphy in follow-up of differentiated thyroid carcinoma. J Nucl Med 1997; 38: 348-352.
13. Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Gomez I, Lind P. Thyroglobulin and low-dose iodine-131 and technetium-99m tetrofosmin whole body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 1998; 39: 870-875.
14. Tonami N, Bunko H, Michigishi T, Kuwajima A, Hisada K. Clinical application of Tl-201 scintigraphy with cold thyroid nodules. Clin Nucl Med 1977; 2: 75-81.
15. Ochi H, Sawa H, Fukuda T et al. Thallium-201 chloride thyroid scintigraphy to evaluate benign and/or malignant nodules. Cancer 1982; 50: 236-240.
16. Feine U, Lietzenmayer R, Hanke JP, Held J, Wohrle H, Muller-Schauenburg W. Fluorine-18-FDG and iodine-131-iodine uptake in thyroid cancer. J Nucl Med 1996; 37: 1468-1472.
17. Grunwald F, Schmburg A, Bender H et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1996; 23: 312-319.
18. Dietlein M, Scheidhauser K, Voth E, Theissen P, Schicha H. Fluorine-18 fluorodeoxyglucose and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1997; 24: 1342-1348.
19. Chung JK, So Y, Lee JS et al. Value of FDG PET in papillary thyroid carcinoma with negative I-131 whole-body scan. J Nucl Med 1999; 40: 986-992.
20. Grunwald F, Menzel C, Bender H et al. Comparison of FDG-PET with iodine-131 and Tc-99m-sestamibi scintigraphy in differentiated thyroid cancer. Thyroid 1997; 7: 327-335.
21. Miyamoto S, Kasagi K, Misaki T, Alam MS, Konishi J. Evaluation of Technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma. J Nucl Med 1997; 38: 352-356.
22. Yen TC, Lin HD, Lee CH, Chang SL, Yeh SH. The role of technetium-99m sestamibi whole-body scans in diagnosing metastatic Hurthle cell carcinoma of the thyroid gland after total thyroidectomy: a comparison with iodine-131 and thallium-201 whole-body scans. Eur J Nucl Med 1994; 21: 980-983.
23. Nishiyama Y, Kawasaki Y, Yamamoto Y et al. Technetium-99m-MIBI and Thallium-201 scintigraphy of primary lung cancer. J Nucl Med 1997; 38: 1358-1361.
24. Unal S, Menda Y, Adalet I et al. Thallium-201, Technetium-99m-tetrofosmin and Iodine in detecting differentiated thyroid carcinoma metastases. J Nucl Med 1998; 39: 1897-1902.
25. Dadparvar S, Chevres A, Tulchinsky M et al. Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation. Eur J Nucl Med 1995; 22: 1330-1338.
26. Songadale JA, Younes A, Maublant J, Veyre A, Platts EA, Pickett RD. Uptake of technetium-99m tetrofosmin in isolated mitochondria: evidence for an active mechanism. J Nucl Med 1994; 35: 46P-47P.